Suppr超能文献

高催乳素血症诊断中的挑战与陷阱

Challenges and pitfalls in the diagnosis of hyperprolactinemia.

作者信息

Vilar Lucio, Fleseriu Maria, Bronstein Marcello D

机构信息

Division of Endocrinology, Hospital das Clínicas, Universidade Federal de Pernambuco, Recife, PE, Brazil.

Departments of Medicine and Neurological Surgery, Northwest Pituitary Center, Oregon Health & Science University, Portland, OR, USA.

出版信息

Arq Bras Endocrinol Metabol. 2014 Feb;58(1):9-22. doi: 10.1590/0004-2730000003002.

Abstract

The definition of the etiology of hyperprolactinemia often represents a great challenge and an accurate diagnosis is paramount before treatment. Although prolactin levels > 200-250 ng/mL are highly suggestive of prolactinomas, they can occasionally be found in other conditions. Moreover, as much as 25% of patients with microprolactinomas may present prolactin levels < 100 ng/mL, which are found in most patients with pseudoprolactinomas, drug-induced hyperprolactinemia, or systemic diseases. On the other hand, some conditions may lead to falsely low PRL levels, particularly the so-called hook effect, that is an assay artifact caused by an extremely high level of PRL, and can be confirmed by repeating assay after a 1:100 serum sample dilution. The hook effect must be considered in all patients with large pituitary adenomas and PRL levels within the normal range or only modestly elevated (e.g., < 200 ng/mL). An overlooked hook effect may lead to incorrect diagnosis and unnecessary surgical intervention in patients with prolactinomas. Another important challenge is macroprolactinemia, a common finding that needs to be identified, as it usually requires no treatment. Although most macroprolactinemic patients are asymptomatic, many of them may present galactorrhea or menstrual disorders, as well as neuroradiological abnormalities, due to the concomitance of other diseases. Finally, physicians should be aware that pituitary incidentalomas are found in at least 10% of adult population.

摘要

高催乳素血症病因的定义常常是一项巨大挑战,在治疗前进行准确诊断至关重要。尽管催乳素水平>200 - 250 ng/mL高度提示催乳素瘤,但偶尔也可见于其他情况。此外,多达25%的微催乳素瘤患者催乳素水平可能<100 ng/mL,而大多数假性催乳素瘤、药物性高催乳素血症或全身性疾病患者也会出现这种情况。另一方面,某些情况可能导致催乳素水平假性降低,尤其是所谓的钩状效应,这是一种由极高水平的催乳素引起的检测假象,可通过将血清样本按1:100稀释后重复检测来确认。所有患有大型垂体腺瘤且催乳素水平在正常范围或仅轻度升高(如<200 ng/mL)的患者都必须考虑钩状效应。忽视钩状效应可能导致催乳素瘤患者诊断错误和不必要的手术干预。另一个重要挑战是巨催乳素血症,这是一种常见情况,需要识别出来,因为它通常无需治疗。尽管大多数巨催乳素血症患者无症状,但由于合并其他疾病,他们中的许多人可能出现溢乳或月经紊乱,以及神经放射学异常。最后,医生应该意识到,至少10%的成年人群中会发现垂体意外瘤。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验